| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 8, 2002
From the Department of Clinical Neurosciences, St George's Hospital Medical School, London, United Kingdom. * To whom correspondence should be addressed. E-mail: a.hassan{at}sghms.ac.uk.
Background and PurposeCerebral autosomal dominant arteriopathy subcortical infarcts and leukoencephalopathy (CADASIL) is a monogenic disorder typified by early onset lacunar strokes, subcortical dementia, psychiatric disturbances, and migraine. Mutations in the Notch3 gene are responsible. Atypical phenotypes have been recognized, and the disease is probably underdiagnosed in the wider stroke population. Therefore, we determined the yield of screening for Notch3 mutations in lacunar stroke with or without leukoaraiosis. MethodsTwo hundred eighteen consecutive patients were studied. All had brain and carotid imaging. Polymerase chain reaction-single-stranded conformational polymorphism analysis was used to screen exons 3, 4, 5, and 6 of the Notch3 gene for mutations and polymorphisms. ResultsA single mutation in exon 4 (C697T) was identified in a young patient, giving an overall carrier frequency of 0.05% (95% CI, 0.0 to 2.0). For patients with onset of lacunar stroke at ConclusionsNotch3 mutations are rare in patients with typical strokes due to cerebral small-vessel disease. In the absence of classic features suggestive of CADASIL, screening for Notch3 mutations has a low yield.
Accepted on August 13, 2002
Yield of Screening for CADASIL Mutations in Lacunar Stroke and Leukoaraiosis
Yanbin Dong PhD;
65 years and leukoaraiosis, the yield was 2.0% (95% CI, 0.4 to 10.9).
This article has been cited by other articles:
![]() |
M. Liguori, R. Mazzei, C. Ungaro, I. L. Simone, A. Gambardella, I. Plasmati, F. Fera, U. Aguglia, P. Lanza, F. Bono, et al. CONVENTIONAL MRI AND NOTCH3 GENE SCREENING IN SPORADIC CADASIL Neurology, February 3, 2009; 72(5): 469 - 471. [Full Text] [PDF] |
||||
![]() |
M. D. Napoli and F. Papa C-Reactive Protein and Cerebral Small-Vessel Disease: An Opportunity to Reassess Small-Vessel Disease Physiopathology? Circulation, August 9, 2005; 112(6): 781 - 785. [Full Text] [PDF] |
||||
![]() |
H Markus Genes for stroke J. Neurol. Neurosurg. Psychiatry, September 1, 2004; 75(9): 1229 - 1231. [Full Text] [PDF] |
||||
![]() |
J. E. Simon, J. Parboosingh, A. Clark, D. George, A.-L. Lafontaine, and M. D. Hill A 52-year-old man with cognitive decline, seizure and stroke Can. Med. Assoc. J., April 27, 2004; 170(9): 1393 - 1394. [Full Text] [PDF] |
||||
![]() |
M. J. Alberts Genetics of Cerebrovascular Disease Stroke, February 1, 2004; 35(2): 342 - 344. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |